Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

British Journal of Ophthalmology

Volumn 82, Issue 7, 1998, Pages 725-730

  Chantelau, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A; INSULIN; SOMATOMEDIN C;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LASER COAGULATION; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RETINA MACULA EDEMA; RETINA MACULOPATHY;

EID: 0031846708     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.7.725     Document Type: Article

References (39)

1. Danis RP, Bingaman DP. Insulin-like growth factor-1 retinal microangiopathy in the pig eye. Ophthalmology 1997; 104:1661-9.
2. Grant MB, Mames RN, Fitzgerald C, et al. Insulin-like growth factor-1 acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia 1993;36:282-91.
3. Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischaemia induced retinal neovascularisation. Science 1997;276:1706-8.
4. Grant M, Russell B, Fitzgerald C, et al. Insulin-like growth factors in vitreous. Diabetes 1986;35:416-20.
5. Boulton M, Gregor Z, McLeod D, et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 1997;81:228-33.
6. Chantelau E, Eggert H, Seppel T, et al. Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome. Br J Ophthalmol 1997;81:169-70.
7. Glaser EW, Goldstein S, Phillips LS. Nutrition and somatomedin. Diabetes 1987;36:1152-60.
8. Moskalets E, Galstyan G, Starostina E, et al. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diab Comp 1994;8:45-50.
9. Aldington SJ, Kohner EM, Meurer S, et al for the EURODIAB-IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB-IDDM Complications Study. Diabetologia 1995;38:437-44.
10. LeRoith D. Insulin-like growth factors. N Engl J Med 1997; 336:633-40.
11. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors: studies in diabetics with and without retinopathy. N Engl J Med 1983;309:527-30.
12. Hyer SL, Sharp PS, Sleightholm M, et al. Progression of diabetic retinopathy and changes in serum insulin-like growth factor 1(IGF-1) during continuous subcutaneous insulin infusion (CSII). Horm Metabol Res 1989;21:18-22.
13. Dills DG, Moss SE, Klein R, et al. Is insulin-like growth factor 1 associated with diabetic retinopathy? Diabetes 1990;39:191-5.
14. Wang Q, Dills DG, Klein R, et al. Does insulin-like growth factor 1 predict incidence and progression of diabetic retinopathy? Diabetes 1995;44:161-4.
15. Chantelau E, Kohner EM. Why some cases of retinopathy worsen when diabetic control improves. BMJ 1997;315: 1105-6.
16. Kingsley R, Ghosh G, Lawson P, et al. Severe diabetic retinopathy in adolescents. Br J Ophthalmol 1983;67:73-89.
17. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, et al for Diabetes Group. Rapid tightening of blood glucose control leads to transient deterioration of diabetic retinopathy in insulin-dependent diabetes mellitus: the Oslo Study. BMJ 1985;290:811-15.
18. Kroc Collaborative Study Group. Diabetic retinopathy after 2 years of intensified insulin treatment. JAMA 1988,260: 37-11.
19. Carroll PB, Herskowitz RD, Goodman AD, et al. Rapid onset of severe retinopathy, cataracts and neuropathy in young patients with diabetes mellitus. Acta Paediatr 1992;8:355-8.
20. Agardh CD, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type-1 insulin-dependent diabetes mellitus after improved metabolic control. J Diab Comp 1992;6:96-100.
21. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
22. Spranger J, Bühnen J, Meyer-Schwickerath R, et al. Anstieg von IGF-1, IGF-2 und IGFBP-3 im menschlichen Glaskörper als Konsequenz einer Blut-Retina-Schrankenstörung bei Patienten mit proliferativer diabetischer Retinopathie. (Abstract.) Diab Stoffw 1998; 7(Suppl 1):32.
23. Hussain MA, Studer K, Messmer EP, et al. Treatment with insulin-like growth factor I alters capillary permeability in skin and retina. Diabetes 1995;44:1209-12.
24. Genentech/Roche Inc. IGF-1 in diabetes. Clinical background brochure. London, 1996.
25. Li W, Liu X, Yanoff M, et al. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endithelial cells. Diabetologia 1996;39:537-47.
26. Schlingemannn RO, van Hinsbergh VWM. Role of vascular permeability factor/vascular endothelial growth factor on eye disease. Br J Ophthalmol 1997;81:501-12.
27. Aiello LP, Northrup KM, Keyt BA, et al. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-44.
28. Averbukh EA, Weiss O, Yanko R, et al. IGF system gene expression in hypoxic retina. (abstract) Diabetologia 1997; 40(Suppl 1):A 493.
29. Punglia RS, Lu M, Hsu J, et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor 1. Diabetes 1997;46:1619-26.
30. Al-Mrayat M, Sharp P, Chong P. Circulating vascular endithelial growth factor in diabetic patients. (abstract) Diabetic Med 1997;14(Suppl 4):S 39.
31. Burgos R, Simo R, Audi L, et al. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia 1997; 40:1107-9.
32. Bhaumick B, Danilkewich AD, Bala RM. Insulin-like growth factors (IGF) I and II in diabetic pregnancy: suppression of normal pregnancy-induced rise of IGF-I. Diabetologia 1986;29:792-7.
33. Roger D, Sherman LD, Gabbay KH. Effect of puberty on insulin-like growth factor I and HbA1 in type-1 diabetes. Diabetes Care 1991;14:1031-5.
34. Klein BEK, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care 1990;13:1034-8.
35. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631-7.
36. Lundbaek K, Jensen VA, Olsen TS, et al. Diabetes, diabetic angiopathy, and growth hormone. Lancet 1970;ii:131-3.
37. Sharp PS, Fallon TJ, Brazier OJ, et al. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation or treatment of proliferative diabetic retinopathy. Diabetologia 1987;30:199-207.
38. Shigetou M, Sagawa T, Ishibashi T, et al. Exacerbation of diabetic retinopathy following systemic insulin-like growth factor-1. Jpn J Clin Ophthalmol 1997;51:1251-5.
39. Rosenlund EF, Haakens K, Brinchmann-Hansen O, et al Transient proliferative diabetic retinopathy during insulin treatment. Am J Ophthalmol 1988;105:618-25.